Synthetic Biologics, Inc. (SYN)

EBITDA

-$9.67M

TTM · Period ending: · USD

SYN logo

SYN EBITDA

Latest reported-$9.67M
SYN TTM EBITDA (-$1.95M → -$9.67M)
High-resolution chart · PNG

SYN ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Synthetic Biologics, Inc. EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-9,666,000
-19,402,000
-19,400,000
-17,287,000
-21,442,000
-12,629,000
-18,475,000
-23,672,000
-21,784,000
-22,552,919
-21,613,919
-20,720,919
-19,368,919
-17,637,000
-15,928,000
-14,178,000
-11,007,000
-9,802,000
-9,461,000
-9,864,000
-10,869,000
-13,879,000
-14,519,000
-15,063,000
-15,089,000
-13,643,000
-14,299,000
-13,094,000
-7,063,000
-14,315,000
-14,384,000
-14,928,000
-20,180,000
-17,613,000
-19,079,000
-27,098,000
-35,718,000
-34,173,000
-42,123,000
-43,665,000
-39,189,000
-37,339,000
-28,279,000
-19,764,000
-17,505,000
-15,959,000
-13,892,000
-12,274,000
-20,114,000
-18,674,000
-18,042,000
-17,005,000
-8,067,451
-7,222,749
-7,025,204
-7,947,999
-5,607,176
-5,175,098
-2,450,262
-1,342,343
-1,561,029
-1,461,625
-3,316,840
-3,340,729
-3,164,408
-3,948,348
-4,831,694
-6,800,535
-9,051,108
-9,776,806
-9,840,537
-9,692,904
-10,707,788
-8,651,092
-6,922,544
-4,598,102
-524,652
-539,894
14,857,090
30,734,940
46,984,940
46,083,775
29,650,004
12,946,065
-6,510,107
-8,771,710
-10,791,077
-12,076,305
-11,173,225
-9,609,691
-8,175,437
-6,899,929
-6,003,058
-5,881,926
-17,526,792
-17,575,452
-17,459,231
-17,071,129
-4,700,000
-4,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.